CLINICAL_TRIALS
trial_result
· 2015-08-26
Clinical Trial Update: A Pharmacokinetic/Pharmacodynamic Study of RO5185426 in Previously Treated Patients With Metastatic Melanoma [Phase 1]
Summary
Phase 1 pharmacokinetic/pharmacodynamic study of RO5185426 in patients with previously treated metastatic melanoma; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2015-08-26